Fansidar Combi Tablets – Dual-Action Antimalarial Therapy
Fansidar Combi Tablets offer a reliable combination treatment for malaria, particularly effective in regions with resistance to chloroquine. This formulation contains two synergistic antimalarial agents—sulfadoxine and pyrimethamine—that work together to stop the growth of malaria parasites in the blood.
Product Details
- Brand: Fansidar
- Pack Size: 150 tablets
- Form: Oral tablet
- Drug Class: Antimalarial (Antifolate combination)
Composition & Ingredients
Each tablet contains:
- Sulfadoxine – 500 mg
- Pyrimethamine – 25 mg
Inactive Ingredients may include: Lactose, maize starch, magnesium stearate, microcrystalline cellulose, and other pharmaceutical-grade excipients depending on the manufacturer.
Uses and Indications
Fansidar is used for the treatment of uncomplicated malaria caused by Plasmodium falciparum. It is especially useful where chloroquine resistance is present. It may also be prescribed as intermittent preventive therapy during pregnancy (IPTp), following national malaria treatment guidelines.
Key Benefits
- Effective in treating chloroquine-resistant malaria
- Combination formula enhances antimalarial efficacy
- Convenient dosage – often used as a single or short-term course
- Recommended for preventive use in specific at-risk populations
How to Use
Fansidar should be used strictly as directed by a healthcare professional. Typical usage includes a single-dose treatment for uncomplicated malaria. Never exceed the recommended dosage. Always complete the full course if prescribed.
Safety Information
- Not suitable for individuals allergic to sulfa-containing drugs
- Use with caution in people with liver or kidney impairment
- May cause side effects like skin reactions, nausea, or blood cell disorders
- Consult a doctor before use during pregnancy, breastfeeding, or when taking other medications